In the absence of a cure for dementia, prevention is vital, and a new study offers evidence that this can be done through the careful control of diabetes, investigators say.
Each individual component of the composite outcome was significantly higher among statin users
Participants taking alendronate were 36% less likely to have new-onset type 2 diabetes than their peers who did not take the drug, according to a large, 10-year study in Denmark.
Diabetes type 2 is linked to severe COVID-19 illness, but a type of drug used to improve glycemic control and weight loss may also reduce complications from the viral disease, a new study finds.
Low amyloid burden and favorable cognitive outcomes seen with DPP-4i use in Alzheimer disease-related cognitive impairment with diabetes
The high price tag and lack of coverage for high-performing anti-obesity drug Wegovy begs the question of what the benefits of weight loss are worth to insurers and patients.
Semglee (insulin glargine-yfgn) is biosimilar to and interchangeable with Lantus (insulin glargine), provides cost-effective option
Needs assessment survey conducted in response to increasing clinical burden of nonalcoholic fatty liver disease, nonalcoholic steatohepatitis
Regular versus poor antidepressant use tied to lower risk for advanced diabetic complications, mortality in patients with depression and diabetes
Multivariable-adjusted hazard ratios for all-cause mortality reduced for one to 59, 60 to 149, 150 to 299, and ≥300 minutes/week
Please login or register first to view this content.